We are pleased to present the 2023 Margie and Robert E. Petersen Research Symposium posters
(Click on the poster image to download the PDF)
Loss of DAXX protein expression results in increased radiosensitivity and decreased ischemic sensitivity of BON-1 cells
Jessica C. Puzzuoli PhD, CT(ASCP)[1], | Caleb Solivio [2], | Christopher M. Heaphy PhD [3], | Eric Chan [1], | Etay Ziv MD, PhD[1]
Memorial Sloan Kettering Cancer Center[1], California University of Science and Medicine[2], Boston University Chobanian & Avedisian School of Medicine[3]
Accelerating the Development of Peptide-Based NET Tracers with ‘Next-Gen’ 18F Chemistry
Cory Z. Zaparaniuk (1), | Kevina Chavda (2), | Shereecia M. Bangura (3), | Derek M. Morim (3), | Eric W. Price (1) and James A.H. Inkster (1)
(1)Dept. of Chemistry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada; (2)Dept. of Chemistry & Chemical Biology, McMaster University, Hamilton, Ontario, Canada; (3)Nuclear Operations & Facilities, McMaster University, Hamilton, Ontario. Canada.
Multi-Institutional Landscape of Somatic Genetic Variants in Pancreatic Neuroendocrine Tumors
Leanne M. Brown (1), | Ryan A. Hagenson (1), | Jason M. Sheltzer (1), | Pamela L. Kunz (2), | John W. Kunstman (1)
(1) Yale School of Medicine, Department of Surgery, New Haven, CT 06511, USA. (2) Department of Medicine, Yale School of Medicine, New Haven, CT, USA.
Glutamate dehydrogenase – a potential target for SDHB-mutated pheochromocytomas and paragangliomas treatment
Mouna Tababi, Peter Söderkvist, Oliver Gimm
Department of Biomedical and Clinical Sciences (BKV)/Division Cell Biology Linköping University, Sweden
Canine adrenomedullary and pheochromocytoma organoids an in vitro animal model
Marit F. van den Berg, Elpetra P.M. Timmermans-Sprang, Fleur C. Viets, Monique E. van Wolferen, Hans S. Kooistra, Sara Galac
Department of Clinical Sciences Faculty of Veterinary Medicine, Utrecht, The Netherlands
Enhanced functionality of 3rd generation CAR-T cells mediated by activation of the IL23 cytokine pathway
Annapurna Pranatharthi Haran (1), | Azin Aghamajidi (1), | Yifan Xiang (1), | Zijie Feng (1), | Noam Auslander (1,2), | Xianxin Hua(1)
(1) Department of Cancer Biology, Abramson Family Cancer Research Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
(2) The Wistar Institute, Philadelphia, PA, 19104, USA.
Increasing the Therapeutic Window in PRRT with Long-acting Somatostatin Analogues: Study Protocol
Else Aalbersberg, Daphne de Vries-Huizing, Michelle Versleijen, Margot Tesselaar, Jeroen Hendrikx, Chayenne Veerman, Mutamba Kayembe, Erik-Jan Rijkhorst, Marcel Stokkel
Netherlands Cancer Institute, Amsterdam, the Netherlands
Single-Cell Transcriptome Analysis Reveals Mechanisms of Tumor Immune Escape in NETs
Alexandra E. Adams (1), | Fuqian Shi (1), | Ziqiang Yuan (1), | Svetlana Bagdasarov (1), | Chang Chan (1), | Edmund Lattime (1), | Steven K. Libutti (1)
1. Rutgers Cancer Institute of New Jersey, Division of Surgical Oncology
Somatic variants in primary and metastatic pheochromocytomas and paragangliomas
Andrew Pregnall, Bradley Wubbenhorst, Katherine L. Nathanson, Heather Wachtel
The University of Pennsylvania, Philadelphia, PA
Identifying Biomarkers for Prognosis and Treatment Selection in Metastatic Neuroendocrine Tumors
Daniel Ackerman 1,2, | Elise R. Seyferth 1,2,3, | Wuyan Li1 ,2, | Daniel DePietro 1,2,3, | Abashai Woodard 1,2,3, | Michael Soulen 1,2,3, | Terence P. F. Gade 1,2,3,4
(1) Penn Image-Guided Interventions Lab, University of Pennsylvania; (2) Department of Radiology, Hospital of the University of Pennsylvania; (3) Division of Interventional Radiology, Department of Radiology, Hospital of the University of Pennsylvania; (4) Department of Cancer Biology, University of Pennsylvania
Targeting MUC1-C in pancreatic neuroendocrine tumor
Hiroki Ozawa (1,2), | Naoki Haratake (1), | Ayako Nakashoji (1), | Tatsuaki Diamon (1), | Atrayee Bhattacharya (1), | Keyi Wang (1), | Kazumasa Fukuda (2), | Yohei Masugi (3), | Minoru Kitago (2), | Yuko Kitagawa (2), and Donald Kufe (1)
(1) Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
(2) Department of Surgery, Keio University School of Medicine, Tokyo, Japan
(3) Department of Pathology, Keio University School of Medicine, Tokyo, Japan